Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
News and Events

Medicilon Events

Hot information:
Two Innovative Service Platforms of Medicilon were Selected as Shanghai International Service Trade Demonstration project| Medicilon Assisted DAC Biotechnology's Fourth ADC Drug DXC007 Getting Approved for Clinical Use| Receiving market recognition! Medicilon won the 2020 "Golden Bull Science and Technology Innovation Award"
Aug 13,2020
Application of Solid Dispersion Technology in Formulation Development
On July 20, 2020, DAC Biotech’s new ADC drug development, TROP2-ADC—DAC-002 was approved of clinical study by NMPA. for the indication of solid malignant tumor.
More
Application of Solid Dispersion Technology in Formulation Development
Jun 30,2020
Convalife and Medicilon announced a strategic pact to jointly conduct preclinical research
Chuansha, Shanghai, June 29, 2020. — Convalife and Medicilon signed a strategic pact, initiating a long-term cooperation between the two companies. Based on previous cooperation
More
Convalife and Medicilon announced a strategic pact to jointly conduct preclinical research
Jun 15,2020
Medicilon will participate 2020 SAPA Healthcare Investment Forum & Roadshow
Due to the COVID-19 pandemic, the 2020 SAPA Healthcare Investment Forum & Roadshow will be divided in 2 parts.  Part I will be hosted as
More
Medicilon will participate 2020 SAPA Healthcare Investment Forum & Roadshow
Jun 10,2020
Medicilon assisted Cosunter in consistency evaluation of the generic drug Heganding with biowaiver
Heganding comes in 100-mg tablets. It’s a treatment for chronic Heptitis B adult patients with ALT rising, active virus replicating and liver decompensation. During the
More
Medicilon assisted Cosunter in consistency evaluation of the generic drug Heganding with biowaiver
Jun 04,2020
Congratualtions to Bio-Thera on obtaining NMPA’s approval of clinical trials of BAT1308
Congratualtions to Medicilon’s partner, Bio-Thera, on obtaining NMPA’s approval of clinical trials of BAT1308. On May 27th, 2020, Bio-Thera Solutions, Ltd, annouced the approval of
More
Congratualtions to Bio-Thera on obtaining NMPA’s approval of clinical trials of BAT1308
Jun 01,2020
Medicilon received the “Most Improved in the Science and Technology” award
Good News! Led by Dr. CHUN-LIN CHEN, the founder and CEO of Shanghai Medicilon Inc., the entreprenuer team in Medicilon received the “Most Improved in
More
Medicilon received the “Most Improved in the Science and Technology” award
May 29,2020
The Deputy Mayor of Haining Municipal Government Yang Wenhua and his team visited Medicilon for the research
On May 21st 2020, the Deputy Mayor of Haining Municipal Government Yang Wenhua and his team visited Medicilon for the research. Dr. Chunlin Chen, Founder
More
The Deputy Mayor of Haining Municipal Government Yang Wenhua and his team visited Medicilon for the research
Apr 22,2020
Medicilon Preclinical Research-Mouse Tumor Model
As the incidence and mortality of cancer have increased year by year, cancer has become the primary enemy threatening human health. Therefore, more and more
More
Medicilon Preclinical Research-Mouse Tumor Model
Apr 21,2020
Formulation Research of Innovative Drugs
Zhangjiang Runhe International Office Garden Opened On April 15, 2020, the opening ceremony of Zhangjiang Runhe International Office Garden was successfully held.  The Member of
More
Formulation Research of Innovative Drugs
Apr 17,2020
Medicilon entered Zhangjiang Runhe International Office Garden as the first batch of contracted enterprises
Malignant tumors, Alzheimer’s disease, diabetes, rheumatoid arthritis… These intractable diseases that threaten human health have long plagued us, bringing pain and suffering to unfortunate patients,
More
Medicilon entered Zhangjiang Runhe International Office Garden as the first batch of contracted enterprises
Apr 16,2020
The Deputy Mayor of Shenzhen Municipal Government Nie Xinping and his team visited Medicilon for the research
On April 10th 2020, the Deputy Mayor of Shenzhen Municipal Government Nie Xinping and his team visited Medicilon for the research.  Dr. Chunlin Chen, Founder
More
The Deputy Mayor of Shenzhen Municipal Government Nie Xinping and his team visited Medicilon for the research
Apr 01,2020
Medicilon CMC-Formulation Department
In 2019, Medicilon has had an extraordinary year. The steadily developing Medicilon made a huge accumulation in 2019 and achieved a qualitative leap.  Let us
More
Medicilon CMC-Formulation Department